Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty
Vaccines · 26.05.2025 · 13 (6) · 565
DOI: 10.3390/vaccines13060565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 26.05.2025. Verfasst von Liang En Wee und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Infectious Diseases, Singapore 308442, Singapore. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background/Objectives: Older adults with frailty are at-risk of worse outcomes following respiratory-viral-infections such as COVID-19. Data on effectiveness of vaccination/boosting in frail older adults during Omicron is lacking.
Methods
National healthcare-claims data and COVID-19 registries were utilized to enroll a cohort of older Singaporeans (≥60 years) as of 1 January 2022, divided into low/intermediate/high-risk for frailty; matching weights were utilized to adjust for sociodemographic differences/vaccination uptake at enrolment across frailty categories. Competing-risk-regression (Fine-Gray) taking death as a competing risk, with matching weights applied, was utilized to compare risks of COVID-19-related hospitalizations and severe COVID-19 across frailty levels (low/intermediate/high-risk), with estimates stratified by booster status. Individuals were followed up until study end-date (20 December 2023).
Results
874,160 older adults were included during Omicron-predominant transmission; ~10% had intermediate/high-frailty-risk. Risk of hospitalization/severe COVID-19 was elevated in those with intermediate/high-frailty-risk up to XBB/JN.1 transmission. Boosting was associated with decreased risk of COVID-19-related hospitalization across all frailty categories in infection-naïve individuals. However, in infection-naïve older adults with high-frailty-risk, while receipt of first boosters was associated with lower risk of COVID-19-hospitalization/severe COVID-19, additional booster doses did not reduce risk. In reinfected older adults, first boosters were still associated with lower hospitalization risk (adjusted-hazards-ratio, aHR = 0.55, 95% CI = 0.33–0.92) among the non-frail, but not in the intermediate/high-frailty-risk minority.
Conclusions
First boosters were associated with reduced adverse COVID-19 outcomes across all frailty categories in infection-naïve older adults during Omicron. However, in the high-frailty minority, boosting did not additionally reduce risk in reinfected individuals with hybrid immunity, and beyond the first booster for infection-naïve individuals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Centre for Infectious Diseases, Singapore 308442, Singapore.
- Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore.
- Department of Infectious Diseases, Singapore General Hospital, Singapore 169608, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
- Ministry of Health, Singapore 169854, Singapore.
- Department of Geriatric Medicine, Changi General Hospital, Singapore 529889, Singapore.
ORCID-Profile: Liang En Wee, Calvin Chiew, Reshma Aziz Merchant, David Chien Boon Lye
Zitieren
APA
Wee, L. E., Loy, E. X. H., Lim, J. T., Kwok, W. H., Chiew, C., Lien, C., Rosario, B. H., Leong, I. Y. O., Merchant, R. A., Lye, D. C. B., & Tan, K. B. (2025). Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty. Vaccines, 13(6), 565. https://doi.org/10.3390/vaccines13060565
Vancouver
Wee LE, Loy EXH, Lim JT, Kwok WH, Chiew C, Lien C, et al. Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty. Vaccines. 2025;13(6):565. doi:10.3390/vaccines13060565
BibTeX
@article{Wee2025,
author = {Wee, Liang En and Loy, Enoch Xue Heng and Lim, Jue Tao and Kwok, Wei Hao and Chiew, Calvin and Lien, Christopher and Rosario, Barbara Helen and Leong, Ian Yi Onn and Merchant, Reshma Aziz and Lye, David Chien Boon and Tan, Kelvin Bryan},
title = {Real-World Effectiveness of Boosting Against Omicron Hospitalization in Older Adults, Stratified by Frailty},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {6},
pages = {565},
doi = {10.3390/vaccines13060565}
}
EUVIMED